David Thomas, MS, CFA, is a biotechnology industry professional with expertise in competitive therapeutic landscapes, financial modeling, policy, investment, and deal trends. David is currently a Senior Advisor at Venture Valuation, focusing on drug valuations and portfolio strategies, and also serves as the Head of Financial and Market Intelligence at ThinkingNode Life Science, Inc. Previously, David was the SVP of Industry Research at the Biotechnology Innovation Organization, where they analyzed R&D, product landscapes, and policy initiatives. Their early career included roles as a biochemist at Amgen, Millennium, and Novartis, as well as at the J Craig Venter Institute. David holds the Chartered Financial Analyst (CFA) designation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices